NSCLC Archive - IOZK

A Single-Arm Phase II Study to Evaluate Efficacy and Safety of First-Line Treatment With DCVAC/LuCa, Standard of Care Chemotherapy and Shenqi Fuzheng Injection in Advanced (Stage IIIB/IV) Non-Small Cell Lung Cancer Patients

2022-01-01/in Dendritic Cells, International Publications, NSCLC /von 2022-01-01 / Integr Cancer Ther 2022;21:15347354221083968

Safety and efficacy of dendritic cell-based immunotherapy (DCVAC/LuCa) combined with carboplatin/pemetrexed for patients with advanced non-squamous non-small-cell lung cancer without oncogenic drivers

2021-12-24/in Dendritic Cells, International Publications, NSCLC /von 2021-12-24 / ESMO Open 2022 Feb;7(1):100334

Modulation of the immune response by heterogeneous monocytes and dendritic cells in lung cancer

2021-11-24/in Dendritic Cells, International Publications, NSCLC /von 2021-11-24 / World J Clin Oncol 2021 Nov;12(11):966-982

Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1

2021-11-02/in Dendritic Cells, International Publications, NSCLC /von 2021-11-02 / Cancers (Basel) 2021 Nov;13(21)

Targeting CD166 lung cancer stem cells: Molecular study using murine dendritic cell vaccine

2021-08-23/in Dendritic Cells, International Publications, NSCLC, SCLC /von 2021-08-23 / Toxicol Appl Pharmacol 2021 Oct;429:115699

MicroRNA-204 plays a role as a tumor suppressor in Newcastle disease virus-induced oncolysis in lung cancer A549 cells

2021-04-21/in International Publications, Newcastle Disease Virus, NSCLC /von 2021-04-21 / Oncol Lett 2021 Jun;21(6):482

A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer

2020-03-17/in Hyperthermia, International Publications, NSCLC /von 2020-03-17 / J Adv Res 2020 Jul;24:175-182

Dendritic cell/cytokine-induced killer cell-based immunotherapy in lung cancer: What we know and future landscape

2019-06-21/in Dendritic Cells, International Publications, NSCLC /von 2019-06-21 / J. Cell. Physiol. 2020 Jan;235(1):74-86

Dendritic-cell vaccine (DCVAC) with first-line chemotherapy in patients with stage IV NSCLC: Final analysis of phase II, open label, randomized, multicenter trial.

2019-06-02/in Dendritic Cells, International Publications, NSCLC /von 2019-06-02 / J Clin Oncol 37, 2019 (suppl; abstr 9039)

Neoantigen-based personalized DC vaccine for lung cancer: An update of translational study.

2019-05-31/in Dendritic Cells, NSCLC /von 2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e20674)